Hypoxic cell death is reduced by pH buffering in a model of engineered heart tissue

Artificial Cells, Blood Substitutes, and Biotechnology

Volumn 36, Issue 2, 2008, Pages 94-113

  Brown, David A ^a   MacLellan, William R ^b   Dunn, James C Y ^c   Wu, Benjamin M ^c   Beygui, Ramin E ^c  

^a Department of Civil and Environmental Engineering   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cardiac tissue engineering; HEPES; Hypoxia

Indexed keywords

CARDIOLOGY; MATHEMATICAL MODELS; MONOLAYERS; TISSUE ENGINEERING;

CARDIAC TISSUE ENGINEERING; POSITIVE CELLS;

CELL DEATH;

4 (2 HYDROXYETHYL) 1 PIPERAZINEETHANESULFONIC ACID; BUFFER; LACTATE DEHYDROGENASE; PROPIDIUM IODIDE;

ACIDITY; ALKALINITY; ANAEROBIC METABOLISM; ANIMAL CELL; ARTICLE; CELL DEATH; ENZYME RELEASE; HEART CELL CULTURE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART TRANSPLANTATION; HYDROGEL; MONOLAYER CULTURE; NEWBORN; NICK END LABELING; NONHUMAN; PH MEASUREMENT; RAT; TISSUE ENGINEERING;

ACIDOSIS; ANIMALS; BUFFERS; CELL DEATH; CELL HYPOXIA; CULTURE MEDIA; HEPES; HYDROGEN-ION CONCENTRATION; IN SITU NICK-END LABELING; ISOELECTRIC POINT; L-LACTATE DEHYDROGENASE; MODELS, BIOLOGICAL; MYOCARDIUM; MYOCYTES, CARDIAC; PROTON PUMPS; RATS; TISSUE CULTURE TECHNIQUES; TISSUE ENGINEERING;

RATTUS;

EID: 42549104684     PISSN: 10731199     EISSN: 15324184     Source Type: Journal    
DOI: 10.1080/10731190801932090     Document Type: Article

References (52)

1. Carrier, R.L., Papadaki, M., Rupnick, M., Schoen, F.J., Bursac, N., Langer, R., Freed, L.E., Vunjak-Novakovic, G. (1999). Cardiac tissue engineering:cell seeding, cultivation parameters, and tissue construct characterization. Biotechnol Bioeng 64:580-589.
2. Zimmermann, W.H., Schneiderbanger, K., Schubert, P., Didie, M., Munzel, F., Heubach, J.F., Kostin, S., Neuhuber, W.L., Eschenhagen, T. (2002). Tissue engineering of a differentiated cardiac muscle construct. Circ Res 90:223-230.
3. Leor, J., Aboulafia-Etzion, S., Dar, A., Shapiro, L., Barbash, I.M., Battler, A., Granot, Y., Cohen, S. (2000). Bioengineered cardiac grafts: A new approach to repair the infarcted myocardium? Circulation 102:III56-61.
4. Shimizu, T., Yamato, M., Isoi, Y., Akutsu, T., Setomaru, T., Abe, K., Kikuchi, A., Umezu, M., Okano, T. (2002). Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ Res 90:e40.
5. Zimmermann, W.H., Fink, C., Kralisch, D., Remmers, U., Weil, J., Eschenhagen, T. (2000). Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. Biotechnol Bioeng 68:106-114.
6. Carrier, R.L., Rupnick, M., Langer, R., Schoen, F.J., Freed, L.E., Vunjak-Novakovic, G. (2002). Effects of oxygen on engineered cardiac muscle. Biotechnol Bioeng 78:617-625.
7. Carrier, R.L., Rupnick, M., Langer, R., Schoen, F.J., Freed, L.E., Vunjak-Novakovic, G. (2002). Perfusion improves tissue architecture of engineered cardiac muscle. Tissue Eng 8:175-188.
8. Malhotra, R., Brosius, F.C., 3rd. (1999). Glucose uptake and glycolysis reduce hypoxia-induced apoptosis in cultured neonatal rat cardiac myocytes. J Biol Chem 274:12567-12575.
9. Nelson D.L., Cox M.M. (2000). Lehninger Principles of Biochemistry. New York: Worth Publishers.
10. Robergs, R.A., Ghiasvand, F., Parker, D. (2004). Biochemistry of exercise-induced metabolic acidosis. Am J Physiol Regul Integr Comp Physiol 287:R502-516.
11. Aki, T., Mizukami, Y., Oka, Y., Yamaguchi, K., Uemura, K., Fujimiya, T., Yoshida, K. (2001). Phosphoinositide 3-kinase accelerates necrotic cell death during hypoxia. Biochem J 358:481-487.
12. Webster, K.A., Bishopric, N. (1992). Molecular regulation of cardiac myocyte adaptation to chronic hypoxia. J Mol Cell Cardiol 24:741-751.
13. Webster, K.A., Discher, D.J., Kaiser, S., Hernandez, O., Sato, B., Bishopric, N.H. (1999). Hypoxia-activated apoptosis of cardiac myocytes requires reoxygenation or a pH shift and is independent of p53. J Clin Invest 104:239-252.
14. Ramanujan, S., Pluen, A., McKee, T.D., Brown, E.B., Boucher, Y., Jain, R.K. (2002). Diffusion and convection in collagen gels: implications for transport in the tumor interstitium. Biophys J 83:1650-1660.
15. Tsang, V.L., Bhatia, S.N. (2004). Three-dimensional tissue fabrication. Adv Drug Deliv Rev 56:1635-1647.
16. Tan, W., Desai, T.A. (2004). Layer-by-layer microfluidics for biomimetic three-dimensional structures. Biomaterials 25:1355-1364.
17. Tan, W., Desai, T.A. (2003). Microfluidic patterning of cells in extracellular matrix biopolymers: effects of channel size, cell type, and matrix composition on pattern integrity. Tissue Eng 9:255-267.
18. Albrecht, D.R., Tsang, V.L., Sah, R.L., Bhatia, S.N. (2005). Photo- and electropatterning of hydrogel-encapsulated living cell arrays. Lab Chip 5:111-118.
19. Ross, R.S., Pham, C., Shai, S.Y., Goldhaber, J.I., Fenczik, C., Glembotski, C.C., Ginsberg, M.H., Loftus, J.C. (1998). Beta1 integrins participate in the hypertrophic response of rat ventricular myocytes. Circ Res 82:1160-1172.
20. Eschenhagen, T., Didie, M., Heubach, J., Ravens, U., Zimmermann, W.H. (2002). Cardiac tissue engineering. Transpl Immunol 9:315-321.
21. Eschenhagen, T., Fink, C., Remmers, U., Scholz, H., Wattchow, J., Weil, J., Zimmermann, W., Dohmen, H.H., Schafer, H., Bishopric, N., Wakatsuki, T., Elson E.L. (1997). Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system. Faseb J 11:683-694.
22. Zimmermann, W.H., Didie, M., Wasmeier, G.H., Nixdorff, U., Hess, A., Melnychenko, I., Boy, O., Neuhuber, W.L., Weyand, M., Eschenhagen, T. (2002). Cardiac grafting of engineered heart tissue in syngenic rats. Circulation 106:I151-157.
23. Brown, D.A., MacLellan, W.R., Dunn, J.C.Y., Wu, B.M., Beygui, R.E. (2007). Analysis of oxygen transport in a diffusion-limited model of engineered heart tissue. Biotech Bioeng 97:962-975.
24. Decker, T., Lohmann-Matthes, M.L. (1988). A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J Immunol Methods 115:61-69.
25. Legrand, C., Bour, J.M., Jacob, C., Capiaumont, J., Martial, A., Marc, A., Wudtke, M., Kretzmer, G., Demangel, C., Duval, D., et al. (1992). Lactate dehydrogenase (LDH) activity of the cultured eukaryotic cells as marker of the number of dead cells in the medium [corrected]. J Biotechnol 25:231-243.
26. Arteel, G.E., Thurman, R.G., Raleigh, J.A. (1998). Reductive metabolism of the hypoxia marker pimonidazole is regulated by oxygen tension independent of the pyridine nucleotide redox state. Eur J Biochem 253:743-750.
27. Raleigh, J.A., Miller, G.G., Franko, A.J., Koch, C.J., Fuciarelli, A.F., Kelly, D.A. (1987). Fluorescence immunohistochemical detection of hypoxic cells in spheroids and tumours. Br J Cancer 56:395-400.
28. Dennis, S.C., Gevers, W., Opie, L.H. (1991). Protons in ischemia: where do they come from, where do they go? J Mol Cell Cardiol 23:1077-1086.
29. Lazdunski, M., Frelin, C., Vigne, P. (1985). The sodium/hydrogen exchange system in cardiac cells: its biochemical and pharmacological properties and its role in regulating internal concentrations of sodium and internal pH. J Mol Cell Cardiol 17:1029-1042.
30. Netti, P.A., Berk, D.A., Swartz, A., Grodzinsky, A.J., Jain, R.K. (2000). Role of extracellular matrix assembly in interstitial transport in solid tumors. Cancer Res 60:2497-2503.
31. Ding, B., Abe, J., Wei, H., Xu, H., Che, W., Aizawa, T., Liu, W., Molina, C.A., Sadoshima, J., Blaxall, B.C., Berk, B.C., Yan, C. (2005). A positive feedback loop of phosphodiesterase 3 (PDE3) and inducible cAMP early repressor (ICER) leads to cardiomyocyte apoptosis. Proc Natl Acad Sci USA 102:14771-14776.
32. Slodzinski, M.K., Blaustein, M.P. (1998). Na+/Ca2+ exchange in neonatal rat heart cells:antisense inhibition and protein half-life. Am J Physiol 275:C459-467.
33. Nakamura, T., Mizuno, S., Matsumoto, K., Sawa, Y., Matsuda, H. (2000). Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF. J Clin Invest 106:1511-1519.
34. Good, N.E., Winget, G.D., Winter, W., Connolly, T.N., Izawa, S., Singh, R.M. (1966). Hydrogen ion buffers for biological research. Biochemistry 5:467-477.
35. Lelong, I.H., Rebel, G. (1998). pH drift of "physiological buffers" and culture media used for cell incubation during in vitro studies. J Pharmacol Toxicol Methods 39:203-210.
36. Ferguson, W.J., Braunschweiger, K.I., Braunschweiger, W.R., Smith, J.R., McCormick, J.J., Wasmann, C.C., Jarvis, N.P., Bell, D.H., Good, N.E. (1980). Hydrogen ion buffers for biological research. Anal Biochem 104:300-310.
37. Good, N.E., Izawa, S. (1972). Hydrogen ion buffers. Methods Enzymol 24:53-68.
38. Poole, C.A., Reilly, H.C., Flint, M.H. (1982). The adverse effects of HEPES, TES, and BES zwitterion buffers on the ultrastructure of cultured chick embryo epiphyseal chondrocytes. In Vitro 18:755-765.
39. Daniel, P.F., Wolf, G. (1975). Incorporation of labeled glucosamines into glycoproteins by organ cultures of hamster trachea: adverse effects of HEPES buffer. In Vitro 11:347-353.
40. Altura, B.M., Altura, B.T., Carella, A., Turlapaty, P. D. (1980). Adverse effects of artificial buffers on contractile responses of arterial and venous smooth muscle. Br J Pharmacol 69:207-214.
41. Altura, B.M., Altura, B.T., Carella, A., Turlapaty, P.D. (1982). Ca2+ coupling in vascular smooth muscle: Mg2+ and buffer effects on contractility and membrane Ca2+ movements. Can J Physiol Pharmacol 60:459-482.
42. Altura, B.M., Carella, A., Altura, B.T. (1980). Adverse effects of Tris. HEPES and MOPS buffers on contractile responses of arterial and venous smooth muscle induced by prostaglandins. Prostaglandins Med 5:123-130.
43. Grady, J.K., Chasteen, N.D., Harris, D.C. (1988). Radicals from "Good's" buffers. Anal Biochem 173:111-115.
44. Simpson, J.A., Cheeseman, K.H., Smith, S.E., Dean, R. (1988). T. Free-radical generation by copper ions and hydrogen peroxide. Stimulation by Hepes buffer. Biochem J 254:519-523.
45. Yamamoto, D., Suzuki, N. (1987). Blockage of chloride channels by HEPES buffer. Proc R Soc Lond B Biol Sci 230:93-100.
46. Kane, J., Macdonald, R.L., Zhang, J., Sima, B. (1997). HEPES inhibits contractile responses of canine basilar artery. Neurol Res 19:527-533.
47. Lepe-Zuniga, J.L., Zigler, J.S., Jr., Gery, I. (1987). Toxicity of light-exposed Hepes media. J Immunol Methods 103:145.
48. Zigler, J.S., Jr., Lepe-Zuniga, J.L., Vistica, B., Gery, I. (1985). Analysis of the cytotoxic effects of light-exposed HEPES-containing culture medium. In Vitro Cell Dev Biol 21:282-287.
49. Spierenburg, G.T., Oerlemans, F.T., van Laarhoven, J.P., de Bruyn, C.H. (1984). Phototoxicity of N-2-hydroxyethylpiperazine-N′-2-ethanesulfonic acid-buffered culture media for human leukemic cell lines. Cancer Res 44:2253-2254.
50. Radisic, M., Deen, W., Langer, R., Vunjak-Novakovic, G. (2005). Mathematical model of oxygen distribution in engineered cardiac tissue with parallel channel array perfused with culture medium containing oxygen carriers. Am J Physiol Heart Circ Physiol 288:H1278-H1289.
51. Radisic, M., Park, H., Chen, F., Salazar-Lazzaro, J.E., Wang, Y., Dennis, R., Langer, R., Freed, L.E., Vunjak-Novakovic, G. (2006). Biomimetic approach to cardiac tissue engineering: oxygen carriers and channeled scaffolds. Tissue Eng 12:2077-2091.
52. Schmaltz, C., Hardenbergh, P.H., Wells, A., Fisher, D.E. (1998). Regulation of proliferation-survival decisions during tumor cell hypoxia. Mol Cell Biol 18:2845-2854.